EPISODE · Jul 17, 2026 · 14 MIN
The Eli Lilly bull case for long-term compounding
from Best Stocks · host ProCap Insights
The company's aggressive investment in AI supercomputing to accelerate drug discovery, alongside the massive success of its incretin and weight-loss medications, positions it well for 2027 and beyond.Full report: https://www.procapinsights.com/ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.
What this episode covers
The company's aggressive investment in AI supercomputing to accelerate drug discovery, alongside the massive success of its incretin and weight-loss medications, positions it well for 2027 and beyond.Full report: https://www.procapinsights.com/ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.
NOW PLAYING
The Eli Lilly bull case for long-term compounding
No transcript for this episode yet
Similar Episodes
Feb 4, 2026 ·18m